Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling

Nature Reviews Immunology

Volumn 3, Issue 7, 2003, Pages 544-556

  Rudd, Christopher E ^a   Schneider, Helga ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLYCOGEN SYNTHASE KINASE 3; IMMUNOGLOBULIN; INDUCIBLE COSTIMULATORY MOLECULE; LYMPHOCYTE ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

CYTOTOXIC LYMPHOCYTE; HUMAN; IMMUNE RESPONSE; INTERNALIZATION; INTRACELLULAR TRANSPORT; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE; T LYMPHOCYTE; TH2 CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL CYCLE PROTEINS; HUMANS; IMMUNOCONJUGATES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 4; MAP KINASE KINASE KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-VAV; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0142259712     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1131     Document Type: Review

References (170)

1. Bretscher, P. A. A two-step, two-signal model for the primary actvation of precursor helper T cells. Proc. Natl Acad. Sci. USA 96, 185-190 (1999).
2. Dustin, M. L. & Shaw, A. S. Co-stimulation: building an immunological synapse. Science 283, 645-650 (1999).
3. Monks, C. R., Freiburg, B. A., Kupher, H., Sciaky, N. & Kupfer, A. Three-dimensional segrgation of supramolecular activation clusters in T cells. Nature 396, 82-86 (1998).
4. Rudd, C. E., Trevillyan, J. M., Dasgupta, J. D., Wong, L. L. & Schlossman, S. F. The CD4 receptor is complexed in detergent lysates to a protein tyrosine kinase (pp58) from human T lymphocytes. Proc. Natl Acad. Sci. USA 85, 5190-5194 (1988).
5. Veillette, A., Bookman, M. A., Horak, E. M. & Bolen, J. B. The CD4 and CD8 T cell surface antigens are associated with the internal tyrosine-protein kinase p56lck. Cell 55, 301-308 (1988).
6. Weiss, A. & Littman, D. R. Signal transduction by lymphocyte antigen receptors. Cell 76, 263-274 (1994).
7. Rao, A., Luo, C. & Hogan, P. G. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15, 707-747 (1997).
8. Peach, R. J. et al. Complementarity determining region 1 (CDR1)-and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1. J. Exp. Med. 180, 2049-2058 (1994).
9. Collins, A. V. et al. The interaction properties of co-stimulatory molecules revisited. Immunity 17, 201-210 (2002).
10. Stamper, C. C. et al. Crystal structure of the B7-1-CTLA-4 complex that inhibits human immune responses, Nature 410, 608-611 (2001).
11. Ikemizu, S. et al. Structure and dimerization of a soluble form of B7-1. Immunity 12, 51-60 (2000).
12. Bluestone, J. New perspectives of CD28-B7 mediated T cell co-stimulation. Immunity 2, 555-559 (1995).
13. Thompson, C. B. Distinct roles for the co-stimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 81, 979-982 (1995).
14. Greenwald, R. J., Latchman, Y. E. & Sharpe, A. H. Negative co-receptors on lymphocytes. Curr. Opin. Immunol. 14, 391-396 (2002).
15. Shahinian, A. et al. Differential T-cell co-stimulatory requirement in CD28-deficient mice. Science 261, 609-612 (1993).
16. Bachmann, M. F. et al. Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus co-stimulation. Immunity 7, 549-557 (1997).
17. H2 developmental pathways: application to autoimmune disease therapy. Cell 80, 707-718 (1995).
18. Schwartz, R. H. T cell clonal anergy. Curr. Opin. Immunol. 9, 351-357 (1997).
19. Coyle, A. J. et al. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity 13, 95-105 (2000).
20. Tafuri, A. et al. ICOS is essential for effective T-helper-cell responses. Nature 409, 105-109 (2001).
21. Dong, C. et al. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 409, 97-101 (2001).
22. McAdam, A. J. et al. ICOS is critical for CD40-mediated antibody class switching. Nature 409, 102-105 (2001).
23. Walunas, T. L. et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405-413 (1994).
24. Krummel, M. F. & Allison, J. P. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183, 2533-2540 (1996).
25. Tivol, E. A. et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547 (1995).
26. Waterhouse, P. et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985-988 (1995).
27. Bachmann, M. F. et al. Normal responsiveness of CTLA-4-deficient anti-viral cytotoxic T cells. J. Immunol. 160, 95-100 (1998).
28. Prasad, K. V. S. et al. T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif. Proc. Natl Acad. Sci. USA 91, 2834-2838 (1994).
29. August, A. & Dupont, B. CD28 of T lmphocytes associates with phosphatidylinositol 3-kinase. Int. Immunol. 6, 769-774 (1994).
30. Pages, F. et al. Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signaling. Nature 369, 327-329 (1994).
31. Truitt, K. E. et al. CD28 delivers co-stimulatory signals independently of its association with phosphatidylinositol-3-kinase. J. Immunol. 155, 4702-4710 (1995).
32. Hutchcroft, J. E. et al. Phorbol ester treatment inhibits phosphatidylinositol 3-kinase activation by, and association with, CD28, a T-lmphocyte surface receptor. Proc. Natl Acad. Sci. USA 91, 3260-3264 (1995).
33. Schneider. H., Prasad, K. V. S., Shoelson, S. E. & Rudd, C. E. CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells. J. Exp. Med. 181, 351-355 (1995).
34. Songyang, Z. et al. SH2 domains recognize specific phosphopeptide sequences. Cell 72, 767-778 (1993).
35. Schneider, H., Cai, Y.-C., Prasad, K. V. S., Shoelson, S. E. & Rudd, C. E. T cell antigen CD28 binds to the GRB-2/SOS complex, regulators of p21 ras. Eur. J. Immunol. 25, 1044-1050 (1995).
36. Kim, H.-H., Tharayil, M. & Rudd, C. E. Growth factor receptor-bound protein 2 SH2/SH3 domain binding to CD28 and its role in co-signaling. J. Biol. Chem. 273, 296-301 (1998).
37. Okkenhaug, K. & Rottapel, R. Grb-2 forms an inducible protein complex with CD28 through a Src homology 3 domain-proline interaction. J. Biol. Chem. 273, 21194-21202 (1998).
38. Ellis, J. H. et al. GRID: a novel Grb-2 related adapter protein that interacts with the activated T cell co-stimulatory receptor CD28. J. Immunol. 164, 5805-5814 (2000).
39. Shiratori, T. et al. Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interacton with clathrin-associated adaptor complex AP-2. Immunity 6, 583-589 (1997).
40. Chuang, E. et al. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. J. Immunol. 159, 144-151 (1997).
41. Schneider, H. et al. Cytolytic T lymphocyte-associated antigen-4 and the TcR-ζ-CD3 complex, but not CD28, interact with clathrin adaptor complexes AP-1 and AP-2. J. Immunol. 168, 1868-1879 (1999).
42. Marengere, L. E. M. et al. The SH3 domain of ltk/Emt binds to proline-rich sequences in the cytoplasmic domain of the T cell co-stimulatory receptor CD28. J. Immunol. 159, 3220-3229 (1997).
43. Holdorf, A. D. et al. Proline residues in CD28 and Src homolgy (SH)3 domain of LCK are required for T cell co-stimulation. J. Exp. Med. 190, 375-384 (1999).
44. lck SH3 domain binds to PI3-kinase but not PI4-kinase. Mol. Cell. Biol. 13, 7708-7717 (1993).
45. Bruyns, E. et al. T cell receptor (TCR) interacting molecule (TRIM), a novel disulfide-linked dimer associated with the TCR-CD3-ζ complex, recruits intracellular signaling proteins to the plasma membrane. J. Exp. Med. 188, 561-575 (1998).
46. tyn regulate CD28 recruitment to phosphatidylinositol 3-kinase, growth factor receptor-bound GRB-2 and T cell-specific protein-tyrosine kinase ITK: implications for co-stimulation. Proc. Natl Acad. Sci. USA 92, 8891-8895 (1995).
47. Miyatake, S., Nakaseko, C., Umemori, H., Yamamoto, T. & Saito, T. Src family tyrosine kinases associate with and phosphorylate CTLA-4 (CD152). Biochem. Biophys. Res. Commun. 249, 444-448 (1998).
48. Schneider, H., Schwartzberg, P. L. & Rudd, C. E. Resting lymphocyte kinase (Rlk/Txx) phosphorylates the YVKM motif and regulates PI 3-kinase binding to T-cell antigen CTLA-4. Biochem. Biophys. Res. Commun. 252, 14-19 (1998).
49. Holdorf, A. D., Lee, K. H., Burack, W. R., Allen, P. M. & Shaw, A. S. Regulation of Lck activity by CD4 and CD28 in the immunological synapse. Nature Immunol. 3, 259-264 (2002). This paper shows that the binding of CD28 to the SH3 domain of LCK leads to its activation and sustained LCK signalling at the T cell-antigen-presenting cell (APC) interface.
50. Harriague, J. & Bismuth, G. Imaging antigen-induced PI3K activation in T cells. Nature Immunol. 3, 1090-1096 (2002).
51. Costello, P. S., Gallagher, M. & Cantrell, D. A. Sustained and dynamic inositol lipid metabolism inside and outside the immunological synapse. Nature Immunol. 3, 1082-1089 (2002).
52. Lu, Y., Phillips, C. A. & Trevillyan, J. M. Phosphatidylinositol 3-kinase activity is not essential for CD28 co-stimulatory activity in Jurkat T cells: studies with a selective inhibitor, wortmannin. Eur. J. Immunol. 25, 533-537 (1995).
53. Cai, Y.-C. et al. Selective CD28pYMNM mutations implicate phosphatidylinositol 3-kinase in CD86-CD28-mediated co-stimulation. Immunity 3, 417-426 (1995).
54. Cefai, D., Cai, Y-C., Hu, H. & Rudd, C. E. CD28 co-stimulatory regimes differ in their dependence on phosphatidylinositol 3-kinase: common cosignals induced by CD80 and CD86. Int. Immunol. 8, 1609-1616 (1996).
55. Shan, X. et al. Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation. Mol. Cell. Biol. 20, 6945-6957 (2000).
56. Harada, Y. et al. Novel role of phosphatidylinositol 3-kinase in CD28-mediated co-stimulation. J. Biol. Chem. 276, 9003-9008 (2001).
57. Harada, Y. et al. Critical requirement for the membrane-proximal cytosolic tyrosine residue for CD28-mediated co-stimulation in vivo. J. Immunol. 168, 3797-3803 (2001).
58. Okkenhaug, K. et al. A point mutation in CD28 distinguishes proliferative signals from survival signals. Nature Immunol. 325, 325-332 (2001). An interesting study showing that mutation of the Tyr residue in the Tyr-Met-Asn-Met motif of CD28 that disrupts the binding of phosphatidylinositol 3-kinase (PI3K) and growth-factor receptor-bound protein 2 (GRB2) interferes with the ability of CD28 to prevent apoptosis in response to high-affinity peptide ligands.
59. Burr, J. S. et al. Cutting edge: distinct motifs within CD28 regulate cell proliferation and induction of Bcl-XL. J. Immunol. 166, 5331-5335 (2001).
60. Yao, Y. & Cooper, G. M. Requirement for phosphatidylinositol 3-kinase in the prevention of apoptosis by nerve growth factor. Science 267, 2003-2006 (1995).
61. Jones, R. G. et al. CD28-dependent activation of protein kinase B/Akt blocks Fas-mediated apoptosis by preventing death-inducing signaling complex assembly. J. Exp. Med. 196, 335-348 (2002). This study shows that active protein kinase B (PKB) can alter the composition of the CD95-associated death-inducing signalling complex (DISC). T cells that express active PKB have reduced activation of caspase-6, pro-apoptotic BID (BH3-interacting domain death agonist) and caspase-3, owing to the impaired recruitment of pro-caspase-6 to the DISC. This supports the notion of an important role for the CD2B-PI3K-phosphoinositide-dependent kinase 1 (PDK1)-PKB pathway in the prevention of apoptosis by CD28, which is mediated by CD95.
62. L does not re-constitute a normal phenotype in the CD28-deficient mice.
63. Frauwirth, K. A. et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 16, 769-777 (2002). The authors report that the increase in glucose transport (that is, expression of the Glut4 receptor) and glycolysis depends on the ligation of CD28. Furthermore, the event is PI3K dependent, and constitutively active PKB could increase glycolysis. This study indicates that the CD28-PI3K interaction regulates glycolysis through CD28-PI3K-mediated regulation of PKB.
64. Diehn, M. et al. Genomic expression programs and the integration of the CD28 co-stimulatory signal in T cell activation. Proc. Natl Acad. Sci. USA 99, 11796-11801 (2002).
65. Appleman, L. J., van Puijenbroek, A. A. F. L., Shu, K. M., Nadler, L. M. & Boussiotis, V. A. CD28 co-stimulation mediates downregulation of p27kip1 and cell cycle progression by activation of the PI3K-PKB signaling pathway in primary human T cells. J. Immunol. 168, 2729-2736 (2002).
66. Ohteki, T. et al. Negative regulation of T cell proliferation and interleukin-2 production by the senne threonine kinase GSK-3. J. Exp. Med. 192, 99-104 (2000).
67. H2 cytokines. Nature Immunol. 2, 37-44 (2001). This paper shows that retroviral expression of constitutively active PKB (AKT) by T cells can provide substitute signals for CD28 in the upregulation of IL-2 production. This underscores the importance of the CD28-associated PI3K-PDK1-PKB pathway in the regulation of cytokine production.
68. Stein, P. H., Fraser, J. D. & Weiss, A. The cytoplasmic domain of CD28 is both necessary and sufficient for co-stimulation of interleukin-2 secretion and association with phosphatidylinositol 3-kinase. Mol. Cell. Biol. 14, 3392-3402 (1994).
69. Raab, M., Pfister, S. & Rudd, C. E. CD28 signaling via Vav/SIp-76 adaptors: regulation of cytokine transcription independent of TCR ligation. Immunity 15, 921-933 (2001). This study shows that low levels of overexpression of VAV and SLP76 (SH2-domain-containing leukocyte proteins of 76 kDa) can convert CD28 into a receptor that can induce the production of IL-2 by Jurkat and primary T cells. This occurred independently of T-cell receptor (TCR) ligation and could provide a pathway to account for in trans co-stimulation mediated by CD28. VAV alone could promote CD28-mediated Induction of IL-2 when expressed at higher levels (see reference 76).
70. Liao, X. C. & Littman, D. R. Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk. Immunity 3, 757-769 (1995).
71. Klasen, S., Pages, F., Peyron, J. F., Cantrell, D. A. & Olive, D. Two distinct regions of the CD28 intracytoplasmic domain are involved in the tyrosine phosphorylation of Vav and GTPase activating protein-associated p62 protein. Int. Immunol. 10, 481-489 (1998).
72. Collins, T. L., Deckert, M. & Altman, A. Views on Vav. Immunol. Today 18, 221-225 (1997).
73. Bustelo, X. R. Regulatory and signaling properties of the Vav family. Mol. Cell. Biol. 20, 1461-1477 (2000).
74. Han, J. et al. Role of substrates and products of PI3-kinase regulating activation of Rac-related guanosine triphosphatases by Vav. Science 279, 558-560 (1998).
75. Inabe, K. et al. Vav3 modulates B cell receptor responses by regulating phosphoinositide 3-kinase activation. J. Exp. Med. 195, 189-200 (2002).
76. Michel, F. et al. CD28 utilizes Vav-1 to enhance TCR-proximal signaling and NF-AT activation. J. Immunol. 165, 3820-3829 (2000).
77. Kaga, S., Ragg, S., Rogers, K. A. & Ochi, A. Stimulation of CD28 with B7-2 promotes focal adhesion-like cell contacts where Rho family small G proteins accumulate in T cells. J. Immunol. 160, 24-27 (1998).
78. Chiang, Y. J. et al. Cbl regulates the CD28 dependence of T-cell activation. Nature 403, 216-220 (2000).
79. Bachmaier, K. et al. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403, 211-216 (2000).
80. Su, B. et al. JNK is involved in signal integration during co-stimulation of T lymphocytes. Cell 77, 727-736 (1994).
81. Salojin, K. V., Zhang, J. & Delovitch, T. L. TCR and CD28 are coupled via ZAP-70 to the activation of the Vav-Rac-1-PAK-1-p38 MAPK signaling pathway. J. Immunol. 163, 844-853 (1999).
82. Marinari, B. et al. Vav cooperates with CD28 to induce NF-κB activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1. Eur. J. Immunol. 32, 447-456 (2002). This study shows that dominant-negative forms of VAV can effectively block the induction of nuclear factor-κB (NF-κB) activation through a pathway that involves RAC1.
83. Moller, A., Dienz, O., Hehner, S. P., Droge, W. & Schmitz, M. L. Protein kinase C-θ cooperates with Vav1 to induce JNK activity in T-cells. J. Biol Chem. 276, 20022-20028 (2001).
84. Villalba, M. et al. A novel functional interaction between Vav and PKC-θ is required for TCR-induced T cell activation. Immunity 12, 151-160 (2000).
85. Bi, K. et al. Antigen-induced translocation of PKC-θ to membrane rafts is required for T cell activation. Nature Immunol. 2, 556-563 (2001).
86. Ghaffan-Tabrizi, N. et al. Protein kinase C-θ, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells. Eur. J. Immunol. 29, 132-142 (1999).
87. Sun, Z. et al. PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes. Nature 404, 402-407 (2000).
88. H cells and regulates their responses. Int. Immunol. 14, 555-566 (2002).
89. Nishida, M. et al. Novel recognition mode between Vav and Grb2 SH3 domains. EMBO J. 20, 2995-3007 (2001).
90. + T cells from receptor/ligand-deficient mice J. Immunol. 169, 3475-3479 (2002).
91. Kann, M. & Ben-Neriah, Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18, 621-663 (2000).
92. Shapiro, V. S., Truit, K. E., Imboden, J. B. & Weiss, A. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites. Mol. Cell. Biol. 17, 4081-4088 (1997).
93. Fraser, J. H., Rincon, M., McCoy, K. D. & Le Gros, G. CTLA-4 ligation attenuates AP-1, NFAT and NF-κB activity in activated T cells. Eur J. Immunol. 29, 838-844 (1999).
94. Lai, J. H. et al. Rel A is a potent transcriptional activator of the CD28 response element with the interleukin 2 promoter. Mol. Cell. Biol. 15, 4260-4271 (1995).
95. Verweij, C. L., Geerts, M. & Aarden, L. A. Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-κB-like element. J. Biol. Chem 266, 14179-14182 (1991).
96. Gerondakis, S., Grossmann, M., Nakamura, Y., Pohl, T. & Grumont, R. Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts. Oncogene 18, 6888-6895 (1999).
97. Kontgen, F. et al. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 15, 1965-1977 (1995).
98. Bryan, R. G. et al. Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells. Mol. Cell Biol. 14, 7933-7942 (1994).
99. Lai, J. H. & Tan, T. H. CD28 signaling causes a sustained downregulation of IκBα which can be prevented by the immunosuppressant rapamycin. J. Biol. Chem. 269, 30077-30080 (1994).
100. Harhaj, E. W. et al. Somatic mutagenesis studies of NF-κB signaling in human T cells: evidence for an essential role of IKKγ in NF-κB activation by T-cell co-stimulatory signals and HTLV-I Tax protein. Oncogene 9, 1448-1456 (2000).
101. Tuosto, L. et al. Mitogen-activated kinase kinase kinase 1 regulates T cell receptor- and CD28-mediated signaling events which lead to NF-κB activation. Eur. J. Immunol. 30, 2445-2454 (2000).
102. Kane, L. P., Shapiro, V. S., Stokoe, D. & Weiss, A. Induction of NF-κB by the Akt/PKB kinase. Curr. Biol. 9, 601-604 (1999).
103. Hehner, S. P. et al. Mixed-lineage kinase 3 delivers CD3/CD28-dedved signals into the IκB kinase complex. Mol. Cell Biol. 20, 2556-2568 (2000).
104. Lin, X., Cunningham, E. T., Jr, Mu, Y., Geleziunas, R. & Greene, W. C. The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-κB acting through the NF-κB-inducing kinase and IκB kinases. Immunity 10, 271-280 (1999).
105. Yamada, T. et al. Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-κB-inducing kinase. J. Immunol. 165, 804-812 (2000).
106. Dimitratos, S. D., Woods, D. F., Stathakis, D. G. & Bryant, P. J. Signaling pathways are focused at specialized regions of the plasma membrane by scaffolding proteins of the MAGUK family. Bioessays 21, 912-921 (1999).
107. Bertin, J. et al. CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-κB. J. Biol. Chem. 276, 11877-11882 (2001).
108. McAllister-Lucas, L. M. et al. Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-κB induction. J. Biol. Chem. 276, 30589-30597 (2001).
109. Wang, D. et al. A requirement for CARMA1 in TCR-induced NF-κB activation. Nature Immunol, 3, 830-835 (2002). This study provides exciting new data implicating the membrane-associated guanylate kinase (MAGUK)-family members CARMA1 in connecting the TCR-CD28 interaction with the activation of inhibitor of NF-κB kinase (IKK) and NF-κB (also see reference 110).
110. Gaide, O. et al. CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-κB activation. Nature Immunol. 3, 836-843 (2002).
111. Ruland, J. et al Bcl10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure. Cell 104, 33-42 (2001). This study implicates BCL10 - a downstream target of CARMA1 - as a new mediator of TCR-CD28-mediated activation of IKK and NF-κB.
112. Lucas, P. C. et al. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-κB signaling pathway. J. Biol. Chem. 276, 19012-19019 (2001).
113. Lin, X., O'Mahony, A., Mu, Y., Geleziunas, R. & Greene, W. C. Protein kinase C-θ participates in NF-κB activation induced by CD3-CD28 co-stimulation through selective activation of IκB kinase-β. Mol. Cell Biol. 20, 2933-2940 (2000).
114. Gaide, O. et al. Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-κB activation. FEBS Lett 496, 121-127 (2001).
115. Kobayashi, K. et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416, 194-199 (2002).
116. Harada, Y. et al. A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible co-stimulator (ICOS). J. Exp. Med. 197, 257-262 (2003).
117. Riley, J. L. et al. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc. Natl Acad. Sci. USA 99, 11790-11795 (2002).
118. H2 cytokines. J. Immunol. 158, 658-665 (1997).
119. Jenkins, M. K. The ups and downs of T cell co-stimulation. Immunity 1, 443-448 (1994).
120. Masteller, E. M., Chuang, E., Mullen, A. C., Reiner, S. L. & Thompson, C. B. Structural analysis of CTLA-4 function in vivo. J. Immunol. 164, 5319-5327 (2000).
121. Fallarino, F., Fields, P. E. & Gajewski, T. F. B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28. J. Exp. Med. 188, 205-210 (1998).
122. Lin, H. et al. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. J. Exp. Med. 188, 199-204 (1998).
123. Bachmann, M. F., Kohler, G., Ecabert, B., Mak, T. W. & Kopf, M. Cutting edge; lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J. Immunol. 163, 1128-1131 (1999).
124. Yin, L., Schneider, H. & Rudd, C. E. Short cytoplasmic SDYMNM segment of CD28 is sufficient to convert CTLA-4 to a positive signaling receptor. J. Leukoc. Biol. 73, 178-182 (2003).
125. Marengere, L. E. M. et al. Regulation of T cell receptor signaling by tyrosine phosphatase Syp association with CTLA-4. Science 272, 1170-1173 (1996).
126. Lee, K. M. et al. Molecular basis of T cell inactivation by CTLA-4. Science 282, 2263-2266 (1998).
127. Chuang, E. et al. The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A. Immunity 13, 313-322 (2000).
128. Chambers, C. A. et al. The lymphoproliferative defect in CTLA-4-deficient mice is ameliorated by an inhibitory NK cell receptor. Blood 15, 4509-4516 (2002).
129. Schneider, H. & Rudd, C. E. Tyrosine phosphatase SHP-2 binding to CTLA-4: absence of direct YVKM/YFIP motif recognition. Biochem. Biophys. Res. Comm. 269, 279-283 (2000).
130. Baroja, M. L. et al. The inhibitory function of CTLA-4 does not require its phosphorylation. J. Immunol. 164, 49-55 (2000).
131. Gadina, M., Stancato, L. M., Bacon, C. M. Larner, A. C. & O'Shea, J. J. Involvement of SHP-2 in multiple aspects of IL-2 signaling: evidence for a positive regulatory role. J. Immunol. 160, 4657-4661 (1998).
132. Nakaseko, C. et al, Cytotoxic lymphocyte antigen 4 (CTLA-4) engagement delivers an inhibitory signal through the membrane-proximal region in the absence of the tyrosine motif in the cytoplasmic tail. J. Exp. Med. 190, 765-774 (1999).
133. Cinek, T. Sadra, A. & Imboden J. B. Tyrosine-independent transmission of inhibitory signals by CTLA-4. J. Immunol. 164, 5-8 (2000).
134. Schneider, H., da Rocha Dias, S, Hu, H. & Rudd, C. E. A regulatory role for cytoplasmic YVKM motif in CTLA-4 inhibition of TCR signaling. Eur. J. Immunol. 31, 2042-2050 (2001)
135. Perez, V. L. et el. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement, Immunity 6, 411-417 (1997).
136. Janssens, V. & Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phophatases implicated in cell growth and signalling. Biochem. J. 353, 417-439 (2001).
137. Nakaseko, C, et al. Cytotoxic lymphocyte antigen 4 (CTLA-4) engagement delivers an inhibitory signal through the membrane-proximal region in the absence of the tyrosine motif in the cytoplasmic tail. J. Exp. Med 190, 765-774 (1999).
138. Baroja, M. L. et al, Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A. J. Immunol. 168, 5070-5078 (2002).
139. 2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor ζ and ZAP70. J. Exp. Med. 186, 1645-1653 (1997).
140. Dong, C., Davis, R. J. & Flavell, R. A. Signaling by the JNK group of MAP kinases. J. Clin. Immunol 21, 253-257 (2001).
141. Brunner, M. C. et al. CTLA-4 mediated inhibition of eady early events of T cell proliferaton. J. Immunol, 162, 5813-5820 (1999).
142. Olsson, C., Riesbeck K., Dohlsten, M., Michaeisson, E. & Riebeck, K. CTLA-4 ligation suppresses CD28-induced NF-κB and AP-1 activity in mouse T cell blasts. J. Biol. Chem. 274, 14400-14405 (1999).
143. Cefai, D. et al. CD28 endoytosis is targeted by mutations that disrupt phosphatidylinositol 3-kinase binding and co-stimulation. J. Immunol 160, 2223-2230 (1998).
144. Chuang, E. et al. Regulation of cytotoxic T lymphocyte-associated molecule-4 by src kinases. J. Immunol 162, 1270-1277 (1999).
145. Leung, H. T., Bradshaw, J., Cleaveland, J. S. & Linsley, P. S. Cytotoxic T lymphocyte-associated molecule-4, a high avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplamic tail. J. Biol Chem. 270, 25107-25114 (1995).
146. Barrat, F. J. et al. Defective CTLA-4 cycling pathway in Chediak-Higashi syndrome: a possible mechanism for deregulation of T lymphocyte activation. Proc. Natl Acad. Sci. USA 96, 8645-8650 (1999).
147. Simons, K. & Toomre D. Lipid rafts and signal transduction. Mol. Cell Biol. 1, 31-39 (2000).
148. Magee, T., Pirinen, N., Adler, J., Pagakis, S. N. & Parmryd, I. Lipid rafts: cell surface platforms for T cell signaling. Biol. Res. 35, 127-131 (2002).
149. Xavier, R., Brennan, T., Li, O., McCormack, C. & Seed, B. Membrane compartmentation is required for efficient T cell activation. Immunity 8, 723-732 (1998).
150. Dykstra, M., Cherukun, A., Sohn, H. W., Tzeng, S.-J. & Pierce, S. K. Location is everything: lipid rafts and immune cell signaling. Annu. Rev. Immunol. 21, 457-481 (2003).
151. Viola, A., Schroeder, S., Sakakibara, Y. & Lanzavecchia, A. T lymphocyte co-stimulation mediated by reorganization of membrane microdomains. Science 283, 680-682 (1999). This study was the first to show that CD28 can potentiate the appearance and clustering of lipid rafts on the surface of T cells, thereby providing an alternate mechanism to account for the ability of CD28 to potentiate TCR signalling. It is, however, unlikely to account for the unique aspects of CD28 signalling in T cells.
152. Martin, M., Schneider, H., Azouz, A. & Rudd, C. E. Cytotoxic T lymphocyte antigen 4 potently inhibits cell surface raft expression in its regulation of T cell function. J. Exp. Med. 194, 1675-1681 (2001). The study shows that cytotoxic T lymphocyte antigen 4 (CTLA4) can potently inhibit the appearance of lipid rafts on the surface of primary T cells in response to both CD3 and CD3-CD28 stimulation. Furthermore, the effect of CD28 was found to induce raft expression mainly of peripheral T cells that otherwise would not express rafts in response to TCR ligation. The increase in raft expression by CD28 and its inhibition by CTLA4 is reflected by changes in the presence of associated linker for activation of T cells (LAT).
153. Chikuma, S., Imboden, J. B. & Bluestone, J. A. Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 197, 129-135 (2003) This study provides evidence that CTLA4 might also interfere with the entry of the TCR into rafts on the surface of cells. This underlines the close proximity of CTLA4 with the TCR complex.
154. Tuosto, L. & Acuto, O. CD28 affects the earliest signaling events generated by TCR engagement. Eur. J. Immunol. 28, 2131-2142 (1998).
155. Michel, F., Attal-Bonnefoy G., Mangino, G., Mise-Omata, S. & Acuto, O. CD28 as a molecular amplifier extending TCR ligation and signaling capabilities. Immunity 15, 935-945 (2001).
156. Burack W. R., Lee, K.-H., Holdorf, A. D., Dustin M. L. & Shaw, A. S. Cutting Edge: quantitative imaging of raft accumulation in the immunological synapse. J. Immunol. 169, 2837-2841 (2002)
157. H2 cells. Immunity, 15, 729-738 (2001).
158. Porter, J. C., Bracke, M., Smith, A., Davies, D. & Hogg, N. Signaling through integrin LFA-1 leads to filamentous actin polymerization and remodeling, resulting in enhanced T cell adhesion. J. Immunol. 168, 6330-6335 (2002).
159. Bromley, S. K. et al. The immunological synapse and CD28-CD80 interactions. Nature Immunol. 2, 1159-1166 (2001).
160. Linsley, P. S. et al. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 4, 535-543 (1996)
161. Egen, J. G. & Allison, J. P. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 16, 23-35 (2002).
162. Vanhaesebroeck, B. & Alessi, D. R. The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346, 561-576 (2000).
163. Sasaki, T. et al. Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration. Science 287, 1040-1046 (2000).
164. +/- mice. Science 285, 2122-2125 (1999).
165. Li, T. et al. Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain. Immunity 2, 451-460 (1995).
166. Zheng, Y., Bagrodia, S. & Cerione R. A. Activation of phosphoinositide 3-kinase activity by Cdc42Hs binding to p85. J. Biol. Chem. 269, 18727-18730 (1994).
167. Kang, H., Schneider, H. & Rudd, C. E. Phosphatidylinositol 3-kinase p85 adaptor function in T-cells. J. Biol. Chem. 277, 912-921 (2002).
168. , Fruman, D. A., Snapper, S. B., Yballe, C. M., Davidson, L. & Yu, J. Y. Impaired B cell development and proliferation in the absence of phosphoinositide 3-kinase p85α. Science 283, 393-397 (1999).
169. Suzuki, H. et al. Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3-kinase. Science 283, 390-392 (1999).
170. Parry, R. V. et al. Ligation of the T cell co-stimulatory receptor CD28 activates the serine-threonine protein kinase protein kinase B. Eur. J. Immunol. 27, 2495-2501 (1997).